COL2A1 and acute myeloid leukemia: The results showed that the survival rate of patients with high EPB41L3 expression was significantly reduced (P = 0.011; Figure 6A), and low expression of COL2A1 predicted poor prognosis (P = 0.013; Figure 6B), while there was no significant relationship between the KCNK10 expression and the prognosis of AML (P = 0.681; Figure 6C).